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Abstract
Background: Diffuse noxious inhibitory controls (DNIC) as measured in rat and 
conditioned pain modulation (CPM), the supposed psychophysical paradigm of 
DNIC measured in humans, are unique manifestations of an endogenous descending 
modulatory pathway that is activated by the application of a noxious conditioning 
stimulus. The predictive value of the human CPM processing is crucial when delib-
erating the translational worth of the two phenomena.
Methods: For CPM or DNIC measurement, test and conditioning stimuli were de-
livered using a computer-controlled cuff algometry system or manual inflation of 
neonate blood pressure cuffs, respectively. In humans (n = 20), cuff pain intensity 
(for pain detection and pain tolerance thresholds) was measured using an electronic 
visual analogue scale. In isoflurane-anaesthetized naïve rats, nociception was meas-
ured by recording deep dorsal horn wide dynamic range (WDR) neuronal firing rates 
(n = 7) using in vivo electrophysiology.
Results: A painful cuff-pressure conditioning stimulus on the leg increased pain de-
tection and pain tolerance thresholds recorded by cuff stimulation on the contralat-
eral leg in humans by 32% ± 3% and 24% ± 2% (mean ± SEM) of baseline responses, 
respectively (p < .001). This finding was back-translated by revealing that a compa-
rable cuff-pressure conditioning stimulus (40 kPa) on the hind paw inhibited the re-
sponses of WDR neurons to noxious contralateral cuff test stimulation to 42% ± 9% 
of the baseline neuronal response (p = .003).
Conclusions: These data substantiate that the noxious cuff pressure paradigm ac-
tivates the descending pain modulatory system in rodent (DNIC) and man (CPM), 
respectively. Future back and forward translational studies using cuff pressure al-
gometry may reveal novel mechanisms in varied chronic pain states.
Significance: This study provides novel evidence that a comparable noxious cuff 
pressure paradigm activates a unique form of endogenous inhibitory control in 
healthy rat and man. This has important implications for the forward translation of 
bench and experimental pain research findings to the clinical domain. If translatable 
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1 |  INTRODUCTION
Descending brainstem control pathways regulate spinal no-
ciceptive processing and likely impact the initiation, prop-
agation and maintenance of particular chronic pain states. 
Diffuse noxious inhibitory controls (DNIC) represent a type 
of descending inhibitory pathway that projects to the dorsal 
horn of the spinal cord to modulate pain processing via in-
hibition of wide dynamic range (WDR) neuronal activity, 
as evidenced in rodents (Bouhassira, Villanueva, Bing, & le 
Bars, 1992). This phenomenon is also observed in humans 
(Le Bars, Villanueva, Bouhassira, & Willer,  1992; Roby-
Brami, Bussel, Willer, & Le Bars, 1987; Willer, Le Bars, & 
De Broucker, 1990) and modalities previously used for testing 
the efficiency of the DNIC system in a translational setting 
include electrical, thermal, mechanical and chemical stimuli.
Nowadays the human counterpart of DNIC is referred to as 
conditioned pain modulation (CPM) and CPM paradigms rep-
resent psychophysical protocols that are used to assess reduced 
pain sensitivity due to noxious conditioning (Yarnitsky, 2010). 
CPM is dysfunctional in chronic pain patients (Lewis, Heales, 
Rice, Rome, & McNair,  2012; Yarnitsky, Granot, Nahman-
Averbuch, Khamaisi, & Granovsky,  2012) and underlying 
noradrenergic mechanisms explain the beneficial use of phar-
macotherapies that target top-down monoaminergic signal-
ling (Ossipov, Morimura, & Porreca, 2014). Specifically, both 
tapentadol (μ-opioid receptor agonist and noradrenaline re-
uptake inhibitor (NRI)) and duloxetine (serotonin NRI) reinstate 
dysfunctional CPM in certain chronic pain patients (Niesters 
et al., 2014; Yarnitsky et al., 2012). This back-translates to ro-
dents where translational relevance is suggested by studies that 
highlight a role for α2 adrenoceptor-mediated mechanisms in 
the normal expression of DNIC, as well as in restoration of 
DNIC expression in rodent models of chronicity (Bannister, 
Patel, Goncalves, Townson, & Dickenson, 2015).
Recording DNIC and CPM at the bench and bedside, re-
spectively, offers preclinical and clinical researchers a surrogate 
measure of top-down processing functionality. CPM modulation 
by forebrain mechanisms is likely (Nir, Yarnitsky, Honigman, 
& Granot,  2012), and, even when recorded in anaesthetized 
rodents, the functional expression of DNIC is influenced by 
subcortical brain regions associated with emotional processing 
(Phelps, Navratilova, Dickenson, Porreca, & Bannister, 2019).
Within CPM protocols test stimuli may be applied se-
quentially or in parallel to a noxious conditioning stimulus 
(Baron et al., 2017; Yarnitsky et al., 2012). The use of cuff 
pressure algometry with a cuff-pressure conditioning stim-
ulus is emerging as a tool to assess CPM with moderate to 
high reliability (Graven-Nielsen, Izumi, Petersen, & Arendt-
Nielsen,  2017; Graven-Nielsen, Vaegter, Finocchietti, 
Handberg, & Arendt-Nielsen, 2015). In this study, our novel 
approach evaluated the validity of the CPM paradigm using 
cuff pressure algometry as a tool for testing the efficiency 
of the DNIC system in humans. Specifically, the character-
istics of the conditioning stimulus evoking a CPM response 
in humans were used in a backward translational study; can 
identical pressure conditioning inhibit spinal dorsal horn 
WDR neuronal responses to a pressure cuff test stimulus in 
naïve rats? It was hypothesized that a comparable nociceptive 
cuff-conditioning stimulus would decrease the pain sensitiv-
ity, and WDR neuronal firing, to cuff test-stimuli in humans 
and rats, respectively. Is it possible to link DNIC research 
data collected in rat with CPM research data collected in man 
when using cuff pressure algometry as a tool to evoke de-
scending pain modulatory systems?
2 |  MATERIALS AND METHODS
2.1 | Subjects for the CPM study
Twenty healthy subjects aged between 22 and 54  years 
(30 ± 1.6 mean ± standard error of the mean, 12 women, 8 
men) participated in the study. Subjects were recruited within 
the Wolfson CARD, King's College London. Inclusion cri-
teria specified that subjects should be free of pain and pain 
medication on the day of testing. Exclusion criteria included 
acute or chronic pain conditions, neurological disorders and 
musculoskeletal or inflammatory conditions. Participants 
were requested to not take any non-steroidal anti-inflam-
matory drugs (NSAIDs) in the 24-hr period prior to testing, 
and to avoid excessively strenuous exercise of the legs. All 
participants provided informed consent prior to testing. The 
study was approved by King's College London Research 
Ethics Committee (HR-15/16-2058) and performed accord-
ing to the Helsinki Declaration.
2.2 | Experimental design of the CPM study
Cuff-pressure pain sensitivity and CPM were assessed using 
a computer-controlled cuff algometry system (Nocitech, 
mechanisms underlying dysfunctional endogenous inhibitory descending pathway 
expression (previously evidenced in painful states in rat and man) were revealed 
using cuff pressure algometry, the identification of new analgesic targets could be 
expedited.
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Aalborg University, Denmark), with pressure delivered via 
two 10-cm wide tourniquet cuffs (VBM Medizintechnik 
GmbH, Sulz am Neckar, Germany). Cuff pain intensity was 
measured using an electronic visual analogue scale (VAS). 
The VAS was anchored with ‘no pain’ as 0-cm and ‘worst 
pain imaginable’ as 10-cm. The subject lay supine at a slight 
incline on a medical bench with a pillow placed under the 
head and under the knees, and the cuffs were placed at the 
widest point of the lower leg around the gastrocnemius 
muscle. The test stimuli were ramped increases in pressure 
(1 kPa/s) to a possible maximum of 100 kPa. The VAS was 
used by the subjects to provide continuous ratings of their 
pain intensity during cuff inflation from their first pain (PDT) 
and was operated by sliding a bar along a 10 cm scale an-
chored at ‘no pain’ and ‘max pain’. When the VAS reached 
1 cm, the corresponding cuff pressure was taken as the sub-
ject's PDT (Graven-Nielsen et al., 2015). Once the pressure 
reached the subject's tolerance limit, they pushed the stop 
button on the VAS device and this cuff pressure was taken 
as their pain tolerance threshold (PTT) and cuff deflation oc-
curred immediately. Moreover, the VAS score at PTT was 
extracted and defined as the pressure tolerance level. For 
subjects who reached the maximum pressure of 100  kPa, 
this was taken as their PTT (Hoegh, Petersen, & Graven-
Nielsen, 2018). Cuff algometry parameters were assessed by 
the same experimenter (TMC). Each subject was familiarized 
with the cuff algometry device during a ‘training’ phase at 
the start of the session, with the subject seated and the cuff 
placed around the arm bicep. Subjects were trained on how to 
use the electronic VAS and how to stop cuff inflation. CPM 
was assessed using cuff algometry, with ramped test-stimuli 
(as above to assess PDT and PTT) applied to the dominant 
leg and a conditioning stimulus of tonic cuff pressure applied 
to the non-dominant leg. Baseline measures (PDT and PTT) 
were recorded at the dominant leg followed by a 10-min rest. 
Next, a test-stimulus ramp was given on the non-dominant 
leg to determine the PTT value used to calibrate the condi-
tioning pressure and was followed by a 5-min rest. Lastly, 
CPM was measured using tonic cuff pressure stimulation at 
70% PTT applied to the non-dominant leg and maintained 
until the end of the last test-stimulus. Subjects were asked 
to focus their attention on the sensation of the dominant leg 
and rate their PDT and PTT as before. The conditioning cuff 
stimulation, delivering the tonic cuff pressure, is inflated 3s 
before the test-stimulus cuff inflation begins. Both cuffs were 
deflated once subjects reached their PTT on the dominant 
leg. PDT and PTT values were extracted for each test stimu-
lus. If the PTT was not reached before the 100 kPa safety 
limit it was conservatively estimated as 100 kPa for further 
analysis. The CPM-effect was calculated as the conditioned 
PDT or PPT value minus the similar measures taken at base-
line. The participants were not informed of the experimental 
hypothesis nor the study that their test data would be used 
for. Participants were not told what was expected from them 
further than the instruction to begin moving the electronic 
VAS upon pain detection and to push the terminating button 
upon reaching their pain tolerance limit.
2.3 | DNIC study design: Animals
Male Sprague–Dawley rats (Charles River, UK) were used 
for electrophysiological experiments. Animals were group 
housed on a 12 h:12 h light–dark cycle. Food and water were 
available ad libitum. All procedures described were approved 
by the Home Office and adhered to the Animals (Scientific 
Procedures) Act 1986. Every effort was made to reduce ani-
mal suffering and the number of animals used in accordance 
with the IASP ethic guidelines (Zimmermann, 1983).
2.4 | DNIC study design: Electrophysiology
In vivo electrophysiology experiments were conducted on 
naive rats (weight 250  g  ±  10%) as previously described 
(Urch & Dickenson, 2003). Briefly, animals were anaesthe-
tized and maintained for the duration of the experiment with 
isoflurane (1.5%) delivered in a gaseous mix of N2O (66%) 
and O2 (33%) via trachea tube. Core body temperature was 
monitored and maintained at 37°C by a heating blanket with 
rectal probe. A laminectomy was performed to expose the 
L4-5 segments of the spinal cord. Extracellular recordings 
were made from deep dorsal horn neurons (lamina V-VI) 
using parylene-coated tungsten electrodes (125 μm diameter, 
2 MΩ impedance, A-M systems, USA). All neurons recorded 
were WDR and responded to low- and high-intensity natu-
ral stimuli in a graded manner with coding of increasing in-
tensity. In keeping with the 3Rs, where possible, more than 
one WDR neuron was recorded per animal (for this study 7 
WDR neuronal recordings were made from 5 rats). Neuronal 
firing was captured, amplified (30–40  k times), band-pass 
filtered and digitalized at 20  kHz sampling rate by a CED 
1,401 interface coupled to a Pentium computer with Spike 2 
software (Cambridge Electronic Design; rate functions). The 
experimenter was not blinded to test or conditioning stimulus 
type; however, the endpoint used in the animal study is an 
objective measure free from subjective bias (i.e. total evoked 
spikes to a given stimulus). All electrophysiology procedures 
commenced approximately 2 hr into the light cycle and lasted 
around 2–4 hr in total; upon isolating a single wide dynamic 
range spinal neuron 3 consecutive stable single-unit recording 
trials were performed (<10% variation for von Frey-evoked 
neuronal responses) in order to collect baseline responses be-
fore application of a conditioning stimulus. Following data 
collection, the rat was overdosed on isoflurane (5%) and, upon 
cessation of heartbeat, cervical dislocation was performed.
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2.5 | DNIC study design: conditioning of 
cuff test stimuli
This paradigm was developed to mimic the human cuff al-
gometry design. The setup consisted of two identical neo-
natal pressure cuffs (E-Medical Medical Supplies Neonate 
Disposable BP Cuff, size #2, individually connected to a ma-
nometer and air pump—air-filled 60 ml syringe—for manual 
inflation). For the test stimulus, the first ‘test cuff’ overlaid 
the WDR neuronal receptive field (hind paw). The pressure 
in the test cuff was monitored with the electronic pressure 
amplifier (Neurolog systems), connected via CED1401 to the 
PC and displayed in Spike2 software along the neuronal re-
cording (Cambridge Electronic Design). The number of ac-
tion potentials fired by the WDR neuron upon incremental 
pressure increases of the ‘test cuff’ (pressure ramp, 1.3 kPa/s, 
in the range of 0–40 kPa) was recorded. The procedure was 
repeated in the presence of noxious cuff pressure; the ‘con-
ditioning cuff’ was applied to the contralateral calf and was 
inflated 5 s before the incremental increase in pressure of ‘test 
cuff’. Based on the human study a cuff conditioning intensity 
provoking CPM was extracted and a comparable value used 
in the animal study. The cuff pressure conditioning intensity 
was deemed to be sufficiently noxious based on prior demon-
stration of the recruitment of small diameter afferents using 
cuff pressure as low as 14 kPa (Kucharczyk et al., 2020). The 
ipsilateral (‘dominant leg’) receptive field was chosen as the 
same side from which the WDR neuron was being recorded.
2.6 | Statistical analysis
Statistical analyses were performed using SPSS (version 24; 
IBM Corp, 2016). One-way repeated measures analysis of vari-
ance (ANOVA) was conducted for human studies (within-sub-
ject factor time: baseline, conditioning) for both PDT and PTT 
to evaluate significant contrasts. For animal studies the statistical 
difference in neuronal response to cuff pressure algometry was 
determined using a two-tailed paired Student's t-test. There were 
no missing animals from analysis and no outliers were excluded 
from the analysis. Minimum group sizes were determined by a 
priori  calculations using the following assumptions (α = 0.05, 
1-β = 0.8, ε = 1, effect size range d = 0.5–0.8). Effect sizes of 
conditioning stimulus on mechanical evoked responses were de-
termined from historical datasets; the typical means and variation 
in neuronal sample sizes ranging from 5 to 10 were comparable to 
this study. The animal experimental group contained five animals 
(and 7 single unit recorded cells) to ensure statistical robustness 
while adhering to the ‘3 R’s’ (refine, reduce, replace—https://
www.nc3rs.org.uk/the-3rs). The primary outcome measure 
was a change in the neuronal response. Results are presented as 
mean ± standard error of the mean (SEM) in-text and figures un-
less described otherwise. Significance accepted at p < .05.
3 |  RESULTS
3.1 | Cuff test stimuli for baseline and 
conditioned responses
Three subjects reached 100  kPa (safety limit) when con-
ditioned but none did at baseline. The mean conditioning 
intensity was 70% PTT (41.6  ±  3  kPa) as assessed at the 
non-dominant leg. At the group-level, there was an increase 
in PDT (Table  1; one-way RM-ANOVA; p  <  .001, F(1, 
19) = 23.92) and PTT (one-way RM-ANOVA; p < .001, F(1, 
19) = 99.03) as assessed at the dominant leg when rated in the 
presence of a conditioning stimulus (noxious cuff pressure). 
The difference in PDT and PTT (the ‘CPM effect’) is visu-
alized in representative raw-trace graphs of eight individual 
subjects (Figure 1a-h). A shift in time for reporting of PDT 
and PTT is illustrated when conditioned and quantification of 
the representative traces is shown in Table 2.
3.2 | Diffuse noxious inhibitory 
controls are induced using noxious cuff 
pressure in naïve rats
The number of action potentials fired by WDR neu-
rons upon incremental pressure increase in the ‘test cuff’ 
(pressure ramp, 1.3  kPa/s, in the range of 0–40  kPa) was 
recorded. DNIC were induced by application of continu-
ous noxious cuff pressure (40  kPa, corresponding closely 
to the human group-level mean conditioning pressure) on 
the calf ipsilateral to the WDR neuron being recorded. A 
pronounced reduction in cuff pressure ramp-evoked WDR 
T A B L E  1  Mean cuff algometry parameters (group level)
Mean ± SEM
Pressure detection threshold (kPa)
Baseline 33.5 ± 2.4
Conditioned 44.3 ± 3.2
CPM effect 10.8 ± 2.2
Pressure tolerance threshold (kPa)
Baseline 61.3 ± 3.0
Conditioned 75.9 ± 3.7
CPM effect 14.6 ± 1.5
Pressure tolerance level (VAS)
Baseline 6.4 ± 0.4
Conditioned 6.6 ± 0.4
Note: Mean (±SEM, n = 20) cuff pressure pain detection threshold (PDT), pain 
tolerance threshold (PTT) and visual analogue scores (VAS) of the pain intensity 
at PTT (‘pressure tolerance level’) assessed at the dominant leg at baseline and 
during measurement of conditioned responses. There was a significant group-
level increase in PDT and PTT, respectively (*p < .001).
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F I G U R E  1  Raw pressure-time/VAS traces of eight subjects. A selection of representative raw traces are shown to illustrate the shift in time 
in subjective reporting of pain detection threshold (PDT), and the increase in intensity for pain tolerance threshold (PTT) during constant cuff 
conditioning (orange, conditioned response) compared with baseline (grey). The grey and orange arrows indicate the visual analogue scale (VAS) 
rating at 1 cm at baseline and during the conditioned response, respectively. Moreover conditioned responses (orange) compared with baseline 
(grey) VAS ratings in 50% of subjects are illustrated to comparable cuff test pressure intensities (see summary Table 2)
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neuronal activity (test stimulus) was observed upon DNIC 
activation with the noxious cuff pressure (conditioning 
stimulus). Representative raw traces of four WDR neuronal 
firing rates from four rats highlight the reductions upon ap-
plication of the conditioning stimulus (Figure 2). At a group 
level the inhibitory effect was quantified as an inhibition 
of WDR neuronal response to the noxious cuff pressure 
(Paired Student's t test, p = .003; Figure 3).
4 |  DISCUSSION
This study provides novel evidence that CPM in humans and 
DNIC in animals are commonly activated in the presence of a 
comparable noxious cuff pressure conditioning stimulus, thus 
inhibiting pain sensitivity to cuff pressure stimulation in a dis-
tant, remote body region and reducing the firing rate of extra-seg-
mental wide dynamic range (WDR) dorsal horn neurons when 
T A B L E  2  Summary of raw pressure traces (shown in Figure 1)
Figure 1
Baseline Conditioned % Change
PDT(kPa) PTT(kPa) VAS(cm) PDT(kPa) PTT(kPa) VAS(cm) PDT(kPa) PTT(kPa) VAS(cm)
A 51.3 65.6 3.4 60.6 70.9 2.1 18.3 8.1 −38.1
B 29.7 65.3 8.5 47.5 82.8 8.2 59.8 26.8 −3.4
C 41.2 59.4 9.2 51.0 80.2 9.7 23.6 35.1 4.4
D 56.4 83.0 3.6 67.5 100.4 3.6 19.5 21.0 −0.3
E 25.1 55.3 6.1 41.2 75.3 7.6 64.1 36.3 23.6
F 22.5 45.1 7.2 24.7 54.3 7.9 9.7 20.4 8.7
G 30.8 71.7 8.0 53.5 94.4 7.0 73.7 31.7 −11.9
H 23.8 49.2 4.9 36.1 68.6 7.2 51.7 39.5 46.6
Note: In the representative subjects an average increase of 40.1% was seen for PDT, 27.3% for PTT and 3.7% for VAS rating. Only 50% of these arbitrarily selected 
subjects showed an increase in VAS rating when conditioned despite all showing increases for the other measures.
F I G U R E  2  Diffuse noxious inhibitory control (DNIC) can be quantified using a cuff-cuff paradigm. In vivo single unit recordings of deep 
dorsal horn wide dynamic range (WDR) neurons were performed in naïve rats under light isoflurane anaesthesia. Four representative traces of 
WDR neuronal responses to cuff pressure ramp evoked stimulation of the receptive field (ipsilateral hind paw) for baseline and conditioned 
responses upon concurrent application of noxious cuff pressure (conditioning stimulus; second cuff stimulation on the contralateral calf) are shown 
(a-d). Data represent individual WDR neuronal firing from naïve rats (n = 4 cells from 3 rats). The time window for frequency measurement equals 
the stimulation period of individual test. To summarize, the raw WDR neuronal firing rates in the representative traces: an average decrease of 
69% was seen for DNIC (where the average test firing frequency for the four cells shown was 15.5 Hz and the average DNIC firing frequency was 
4.8 Hz). Relating to the Figure 3 group-level DNIC quantification, trace A is a cell recorded from rat 2, trace B from rat 5, trace c and d from rat 4
A B
C D
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conditioned (during cuff pressure stimulation), respectively. It 
was inferred that WDR neuronal inhibition may be one of the 
mechanisms involved in CPM assessed by cuff algometry in 
humans.
4.1 | Backward translation of CPM to DNIC
CPM and DNIC likely represent an endogenous descend-
ing modulatory pathway that originates supra-spinally and is 
modulated by forebrain mechanisms (Nir et al., 2012; Phelps 
et al., 2019). The ability of the DNIC modulatory pathway to 
inhibit the responses of spinal WDR neurons to a test stimulus 
upon presentation of a noxious ear pinch (conditioning stimu-
lus) in anaesthetized rats has been well documented (Bannister, 
Lockwood, Goncalves, Patel, & Dickenson, 2017; Bannister 
et  al., 2015; Lockwood, Bannister, & Dickenson, 2019), as 
has a process of endogenous central pain modulation upon 
application of varied noxious conditioning stimuli in hu-
mans (Le Bars et al., 1992; Roby-Brami et al., 1987; Willer 
et al., 1990). It remains unknown whether or not conditioned 
pain modulation (CPM) output entirely represents functional 
expression of the endogenous descending inhibitory DNIC 
pathway. However, evidence supports CPM as a relevant 
measure in clinical populations (Kennedy, Kemp, Ridout, 
Yarnitsky, & Rice, 2016; McPhee & Graven-Nielsen, 2019; 
Nahman-Averbuch, Nir, Sprecher, & Yarnitsky, 2016).
Sham-operated rats express DNIC in an identical manner 
to naïve rats, the maintenance of which translates to patient 
data (Bannister et al., 2015). In addition, the magnitude of 
inhibitory effect of DNIC in rodent studies is around 35%, 
similar to the reduction in pain sensitivity documented in 
human studies of CPM (Yarnitsky et al., 2012). Furthermore, 
the translation of DNIC acting on WDR neurons to humans 
is supported by the fact that spinal neurons code the intensity 
and spatial features of stimuli under the same anaesthetic 
conditions in a manner remarkably parallel to human psy-
chophysics (Sikandar, Ronga, Iannetti, & Dickenson, 2013).
Rodent electrophysiology and human psychophysics 
outputs have previously been compared when characteriz-
ing nociceptive processing, and data to show augmented 
evoked activity of rat spinal neurons marries with the altered 
perceptual responses of human subjects to peripheral stim-
ulation in the UVB irradiation model. A correlation in the 
evoked activity of rat spinal neurons to human pain thresh-
olds was reported and parallel results validated the transla-
tional use of both models (O'Neill, Sikandar, McMahon, & 
Dickenson, 2015). Can DNIC and CPM paradigms measur-
ing spinal neuron activity and pain thresholds, respectively, 
be utilized to investigate the functionality of descending 
control systems in health and chronicity? The predictive 
value of the laboratory DNIC model for human pain pro-
cessing is a crucial consideration when deliberating the 
translational worth of the two paradigms. In the first part of 
this translational study the human pain sensitivity was as-
sessed before and concurrent to application of a condition-
ing stimulus using the cuff pressure algometry (baseline 
and conditioned responses, respectively). Decreased pain 
sensitivity to cuff stimulation was demonstrated during 
contralateral conditioning stimulation by a cuff inflated 
to approximately 40 kPa on average, in line with previous 
findings (Graven-Nielsen et al., 2017). In the second part 
of this study the present findings were extended to reveal 
that conditioning noxious cuff pressure (distant noxious 
cuff pressure, 40 kPa) inhibited WDR neuronal responses 
to noxious stimulation of the hind paw when using cuff 
F I G U R E  3  Group level DNIC quantification. Significantly reduced WDR neuronal firings compared with baseline recordings is illustrated 
(Paired Student's t test: **p < .01). Data represent mean ± SEM of seven individual WDR neuronal responses from five naïve rats. The five rats are 
colour coded allowing visualization of cell(s) recorded from: rat 1 (blue, one cell), rat 2 (green, one cell), rat 3 (purple, two cells), rat 4 (black, two 
cells) and rat 5 (orange, one cell). Individual firing frequencies (baseline and conditioned) are quantified in the adjoining table
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pressure as the test stimulus. Small diameter primary af-
ferents (presumably nociceptive) were previously activated 
using this level of cuff pressure stimulation (Kucharczyk 
et al., 2020). Thus, using the cuff pressure algometry with a 
fixed cuff-pressure conditioning stimulus paradigm, it was 
possible to compare rodent DNIC and human CPM func-
tionality. Directly comparable measurable outcomes (using 
equivalent cuff pressures for the conditioning stimuli in 
rodent and man) were obtained and we validate the use of 
the CPM paradigm using cuff pressure algometry as a lab-
oratory tool for testing the efficiency of the DNIC system 
in humans.
4.2 | Major differences when translating 
DNIC and CPM
Behavioural paradigms of DNIC have been documented in 
wakeful animals (Okada-Ogawa, Porreca, & Meng, 2009), 
but the advantage of electrophysiological rodent studies is 
that entirely objective measurements of the inhibitory output 
of the DNIC pathway are made. An important caveat of this 
study is the fact that CPM is measured in awake subjects al-
though based on a user-independent methodology meaning 
that the assessment is run completely independently of the 
experimenter because the cuff algometer is fully computer 
controlled. In humans, cognitive and higher order brain pro-
cesses, such as those involved in emotion, directly influence 
the descending pain modulatory pathways and pain reports 
are thus subjective; the CPM output is considered to be in-
fluenced by the emotional past and present of the test sub-
ject (Tracey & Mantyh,  2007). Extracting the net activity 
in human descending controls from the gross output that is 
human CPM expression remains challenging, and identify-
ing robust methods for separating the ‘noise’ generated by 
cortical and limbic networks will be an important step in 
further validating the CPM paradigm as a measure of endog-
enous analgesia. This is directly linked to a further caveat, 
which relates to the fact that the identical intensity of cuff 
pressure in use as a conditioning stimulus in rat and man 
cannot be fully equated because of the underlying neural 
systems recruited by the stimulus. Nonetheless, the func-
tionality and pharmacology of DNIC/CPM are remarkably 
similar (Bannister et  al.,  2015; Niesters et  al.,  2014), sup-
porting their translational value. Corroborating, drugs that 
act to reassert a balance between monoaminergic descending 
excitations and inhibitions not only restore the expression of 
DNIC but could conceivably be beneficial in the prevention 
of persistent post-operative pain, where impaired CPM is a 
predictor of those patients at risk, although more studies are 
need to support this.
Research to reveal mechanisms underlying dysfunctional 
pain processing in rodent models of chronicity will allow 
steps towards the development of a reliable test that can 
demonstrate activity in descending pathways. Recognizing 
that DNIC and CPM paradigms assessed by cuff algometry 
can offer translational value would be a major step forward.
5 |  CONCLUSION
This study does not claim that DNIC and CPM responses 
are the same. However, the WDR neuronal responses to 
cuff pressure conditioning provide first-step indication of 
the assumption that the cuff algometry is activating the 
descending pain modulatory system in man through inhi-
bition of spinal neuronal activity. From this, it might be 
inferred that the CPM-effect in humans is partly a result 
of the activation of these same mechanisms. The ability 
to measure the expression or the absence of a functional 
descending modulatory pathway could promote personal-
ized pain therapy. Back and forward translational studies 
between DNIC and CPM in various chronic pain states will 
inform mechanistic insights and reveal new therapeutic 
targets, ultimately contributing to the optimization of pre-
scribed analgesic potential.
ACKNOWLEDGEMENT
The authors thank Professor Stephen B. McMahon (King's 
College London) for securing funding for TMC.
CONFLICTS OF INTEREST
The authors have no conflicts of interest to declare. Nocitech 
is partly owned by Aalborg University.
AUTHOR CONTRIBUTIONS
All authors discussed the results, commented on the manu-
script and gave final approval of the version to be published. 
TMC acquired, analysed and interpreted all human data; 
MMK acquired, analysed and interpreted animal data and 
contributed to the design of the project; TGN assisted with 
interpretation of human data and revised critically the manu-
script for important intellectual content; KB conceived, de-
signed, acquired, analysed and interpreted data, and drafted 
and critically revised the manuscript for important intellec-
tual content.
ORCID
Kirsty Bannister   https://orcid.org/0000-0002-3043-3574 
REFERENCES
Bannister, K., Lockwood, S., Goncalves, L., Patel, R., & Dickenson, 
A. H. (2017). An investigation into the inhibitory function of sero-
tonin in diffuse noxious inhibitory controls in the neuropathic rat. 
European Journal of Pain, 21, 750–760. https://doi.org/10.1002/
ejp.979
1338 |   CUMMINS et al.
Bannister, K., Patel, R., Goncalves, L., Townson, L., & Dickenson, A. 
H. (2015). Diffuse noxious inhibitory controls and nerve injury: 
Restoring an imbalance between descending monoamine inhibitions 
and facilitations. Pain, 156, 1803–1811. https://doi.org/10.1097/j.
pain.00000 00000 000240
Baron, R., Maier, C., Attal, N., Binder, A., Bouhassira, D., Cruccu, 
G., … Treede, R. D. (2017). Peripheral neuropathic pain: A mech-
anism-related organizing principle based on sensory profiles. 
Pain, 158, 261–272. https://doi.org/10.1097/j.pain.00000 00000 
000753
Bouhassira, D., Villanueva, L., Bing, Z., & le Bars, D. (1992). 
Involvement of the subnucleus reticularis dorsalis in diffuse noxious 
inhibitory controls in the rat. Brain Research, 595, 353–357. https://
doi.org/10.1016/0006-8993(92)91071 -L
Graven-Nielsen, T., Izumi, M., Petersen, K. K., & Arendt-Nielsen, L. 
(2017). User-independent assessment of conditioning pain modu-
lation by cuff pressure algometry. European Journal of Pain, 21, 
552–561. https://doi.org/10.1002/ejp.958
Graven-Nielsen, T., Vaegter, H. B., Finocchietti, S., Handberg, G., & 
Arendt-Nielsen, L. (2015). Assessment of musculoskeletal pain 
sensitivity and temporal summation by cuff pressure algometry: A 
reliability study. Pain, 156, 2193–2202. https://doi.org/10.1097/j.
pain.00000 00000 000294
Hoegh, M., Petersen, K. K., & Graven-Nielsen, T. (2018). Effects of re-
peated conditioning pain modulation in healthy volunteers. European 
Journal of Pain, 22, 1833–1843. https://doi.org/10.1002/ejp.1279
Kennedy, D. L., Kemp, H. I., Ridout, D., Yarnitsky, D., & Rice, A. S. 
(2016). Reliability of conditioned pain modulation: A systematic 
review. Pain, 157, 2410–2419. https://doi.org/10.1097/j.pain.00000 
00000 000689
Kucharczyk, M. W., Chisholm, K. I., Denk, F., Dickenson, A. H., 
Bannister, K., & McMahon, S. B. (2020). The impact of bone can-
cer on the peripheral encoding of mechanical pressure stimuli. Pain, 
https://doi.org/10.1097/j.pain.00000 00000 001880
Le Bars, D., Villanueva, L., Bouhassira, D., & Willer, J. C. (1992). 
Diffuse noxious inhibitory controls (DNIC) in animals and in man. 
Patologicheskaia Fiziologiia I Eksperimentalnaia Terapiia, 55–65.
Lewis, G. N., Heales, L., Rice, D. A., Rome, K., & McNair, P. J. 
(2012). Reliability of the conditioned pain modulation paradigm 
to assess endogenous inhibitory pain pathways. Pain Research and 
Management, 17, 98–102. https://doi.org/10.1155/2012/610561
Lockwood, S. M., Bannister, K., & Dickenson, A. H. (2019). An in-
vestigation into the noradrenergic and serotonergic contributions of 
diffuse noxious inhibitory controls in a monoiodoacetate model of 
osteoarthritis. Journal of Neurophysiology, 121, 96–104. https://doi.
org/10.1152/jn.00613.2018
McPhee, M., & Graven-Nielsen, T. (2019). Alterations in temporal sum-
mation of pain and conditioned pain modulation across an episode 
of experimental exercise-induced low back pain. Journal of Pain, 
20, 264–276. https://doi.org/10.1016/j.jpain.2018.08.010
Nahman-Averbuch, H., Nir, R. R., Sprecher, E., & Yarnitsky, D. 
(2016). Psychological Factors and Conditioned Pain Modulation: A 
Meta-Analysis. Clinical Journal of Pain, 32, 541–554. https://doi.
org/10.1097/AJP.00000 00000 000296
Niesters, M., Proto, P. L., Aarts, L., Sarton, E. Y., Drewes, A. M., & 
Dahan, A. (2014). Tapentadol potentiates descending pain inhibition 
in chronic pain patients with diabetic polyneuropathy. British Journal 
of Anaesthesia, 113, 148–156. https://doi.org/10.1093/bja/aeu056
Nir, R. R., Yarnitsky, D., Honigman, L., & Granot, M. (2012). Cognitive 
manipulation targeted at decreasing the conditioning pain perception 
reduces the efficacy of conditioned pain modulation. Pain, 153, 
170–176. https://doi.org/10.1016/j.pain.2011.10.010
Okada-Ogawa, A., Porreca, F., & Meng, I. D. (2009). Sustained mor-
phine-induced sensitization and loss of diffuse noxious inhibitory 
controls in dura-sensitive medullary dorsal horn neurons. Journal 
of Neuroscience, 29, 15828–15835. https://doi.org/10.1523/JNEUR 
OSCI.3623-09.2009
O'Neill, J., Sikandar, S., McMahon, S. B., & Dickenson, A. H. (2015). 
Human psychophysics and rodent spinal neurones exhibit peripheral 
and central mechanisms of inflammatory pain in the UVB and UVB 
heat rekindling models. Journal of Physiology, 593, 4029–4042. 
https://doi.org/10.1113/JP270294
Ossipov, M. H., Morimura, K., & Porreca, F. (2014). Descending 
pain modulation and chronification of pain. Current Opinion in 
Supportive and Palliative Care, 8, 143–151.
Phelps, C. E., Navratilova, E., Dickenson, A. H., Porreca, F., & Bannister, 
K. (2019). Kappa opioid signaling in the right central amygdala 
causes hind paw specific loss of diffuse noxious inhibitory controls 
in experimental neuropathic pain. Pain, 160, 1614–1621. https://doi.
org/10.1097/j.pain.00000 00000 001553
Roby-Brami, A., Bussel, B., Willer, J. C., & Le Bars, D. (1987). An 
electrophysiological investigation into the pain-relieving effects of 
heterotopic nociceptive stimuli. Probable involvement of a supra-
spinal loop. Brain, 110(Pt 6), 1497–1508. https://doi.org/10.1093/
brain /110.6.1497
Sikandar, S., Ronga, I., Iannetti, G. D., & Dickenson, A. H. (2013). 
Neural coding of nociceptive stimuli-from rat spinal neurones to 
human perception. Pain, 154, 1263–1273. https://doi.org/10.1016/j.
pain.2013.03.041
Tracey, I., & Mantyh, P. W. (2007). The cerebral signature for pain 
perception and its modulation. Neuron, 55, 377–391. https://doi.
org/10.1016/j.neuron.2007.07.012
Urch, C. E., & Dickenson, A. H. (2003). In vivo single unit extracel-
lular recordings from spinal cord neurones of rats. Brain Research 
Brain Research Protocols, 12, 26–34. https://doi.org/10.1016/S1385 
-299X(03)00068 -0
Willer, J. C., Le Bars, D., & De Broucker, T. (1990). Diffuse noxious 
inhibitory controls in man: Involvement of an opioidergic link. 
European Journal of Pharmacology, 182, 347–355. https://doi.
org/10.1016/0014-2999(90)90293 -F
Yarnitsky, D. (2010). Conditioned pain modulation (the diffuse noxious 
inhibitory control-like effect): Its relevance for acute and chronic 
pain states. Current Opinion in Anaesthesiology, 23, 611–615. 
https://doi.org/10.1097/ACO.0b013 e3283 3c348b
Yarnitsky, D., Granot, M., Nahman-Averbuch, H., Khamaisi, M., & 
Granovsky, Y. (2012). Conditioned pain modulation predicts dulox-
etine efficacy in painful diabetic neuropathy. Pain, 153, 1193–1198. 
https://doi.org/10.1016/j.pain.2012.02.021
Zimmermann, M. (1983). Ethical guidelines for investigations of exper-
imental pain in conscious animals. Pain, 16, 109–110. https://doi.
org/10.1016/0304-3959(83)90201 -4
How to cite this article: Cummins TM, Kucharczyk 
MM, Graven-Nielsen T, Bannister K. Activation of the 
descending pain modulatory system using cuff pressure 
algometry: Back translation from man to rat. Eur J Pain. 
2020;24:1330–1338. https://doi.org/10.1002/ejp.1580
